Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia

BACKGROUND: The increasing availability of different monoclonal antibodies (mAbs) opens the way to more specific biologic therapy of cancer patients. However, despite the significant success of therapy in breast and ovarian carcinomas with anti-HER2 mAbs as well as in non-Hodkin B cell lymphomas wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Loisel, Séverine, André, Pierre-Alain, Golay, Josee, Buchegger, Franz, Kadouche, Jean, Cérutti, Martine, Bologna, Luca, Kosinski, Marek, Viertl, David, Delaloye, Angelika Bischof, Berthou, Christian, Mach, Jean-Pierre, Boumsell, Laurence
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103468/
https://www.ncbi.nlm.nih.gov/pubmed/21504579
http://dx.doi.org/10.1186/1476-4598-10-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103468/
https://www.ncbi.nlm.nih.gov/pubmed/21504579
http://dx.doi.org/10.1186/1476-4598-10-42

Ejemplares similares